Current Issue : HemaSphere

Journal Logo

March 2023 - Volume 7 - Issue 3
pp: e853-e853

Challenges and Opportunities of Precision Medicine in Sickle Cell Disease: Novel European Approach by GenoMed4All Consortium and ERN-EuroBloodNet

Collado, Anna; Boaro, Maria Paola; van der Veen, Sigrid; More

HemaSphere. 7(3):e844, March 2023.

A Lack of Diversity, Equity, and Inclusion in Clinical Research Has Direct Impact on Patient Care

El-Galaly, Tarec Christoffer; Gaidzik, Verena I.; Gaman, Mihnea-Alexandru; More

HemaSphere. 7(3):e842, March 2023.

Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper From an Ad Hoc International Expert Panel

Pagano, Livio; Zinzani, Pier Luigi; Pileri, Stefano; More

HemaSphere. 7(3):e841, March 2023.

Autoimmune Lymphoproliferative Syndrome (ALPS) Disease and ALPS Phenotype: Are They Two Distinct Entities?

Palmisani, Elena; Miano, Maurizio; Grossi, Alice; More

HemaSphere. 7(3):e845, March 2023.

In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell–Related Injury

Federti, Enrica; Matte, Alessandro; Recchiuti, Antonio; More

HemaSphere. 7(3):e848, March 2023.

Impact of Elotuzumab Plus Pomalidomide/Dexamethasone on Health-related Quality of Life for Patients With Relapsed/Refractory Multiple Myeloma: Final Data From the Phase 2 ELOQUENT-3 Trial

Weisel, Katja; Dimopoulos, Meletios A.; San-Miguel, Jesús; More

HemaSphere. 7(3):e843, March 2023.

Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden

Weibull, Caroline E.; Wästerlid, Tove; Wahlin, Björn Engelbrekt; More

HemaSphere. 7(3):e838, March 2023.

Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease Prophylaxis

Hermans, Sjoerd J. F.; Versluis, Jurjen; Labopin, Myriam; More

HemaSphere. 7(3):e846, March 2023.

Excessive Erythrocytosis Is Not Associated With Altered Iron Homeostasis in Men From the World’s Highest City

Cairo, Gaetano; Champigneulle, Benoit; Correnti, Margherita; More

HemaSphere. 7(3):e849, March 2023.

DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients

Malighetti, Federica; Arosio, Giulia; Manfroni, Chiara; More

HemaSphere. 7(3):e852, March 2023.

Impact of Mutational Status and Prognostic Factors on Survival in Chronic Myelomonocytic Leukemia With Systemic Inflammation and Autoimmune Disorders

Dussiau, Charles; Dupuy, Henry; Bidet, Audrey; More

HemaSphere. 7(3):e847, March 2023.

Lenalidomide Consolidation Added to Rituximab Maintenance Therapy in Patients Remaining PET Positive After Treatment for Relapsed Follicular Lymphoma: A Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study

Trotman, Judith; Presgrave, Peter; Carradice, Duncan P.; More

HemaSphere. 7(3):e836, March 2023.